R. Garciamorales et al., EFFECTS OF CHIMERIC CELLS FOLLOWING DONOR BONE-MARROW INFUSIONS AS DETECTED BY PCR-FLOW ASSAYS IN KIDNEY-TRANSPLANT RECIPIENTS, The Journal of clinical investigation, 99(5), 1997, pp. 1118-1129
40 recipients of first cadaver kidney transplants were given periopera
tive donor vertebral bone marrow infusions (DBMC), compared with 100 c
ontrols who did not receive donor bone marrow, The immunosuppressive r
egimen included OKT3, Tacrolimus, and steroid maintenance therapy, and
, in some patients, newly introduced mycophenolate mofetil. This repor
t describes the 24-mo actuarial follow-up and several immunological mo
nitoring studies including sequential measurements of donor bone marro
w lineage subset chimerism by the recently reported PCR-flow assay, Th
is is a sensitive in situ PCR detection system for donor versus recipi
ent histocompatibility genes as well as cell surface CD epitope marker
s using flow cytometry. The results indicate (a) the stabilization of
the donor CD3+ and CD34+ cells in recipient peripheral blood at levels
below 1% between 6 mo and 1 yr postoperatively, with a 10-fold higher
level of donor cell chimerism of these lineages in recipient iliac cr
est marrow; (b) significantly lower levels of chimerism in peripheral
blood up to 6 mo postoperatively in patients who had early acute (reve
rsible) rejection episodes compared with those who did not; (c) a high
er degree of chimerism seen in patients who were class II MHC HLA DR i
dentical with their donors; (c) the identification of a high proportio
n of the donor bone marrow derived CD3 dimly staining subset of T cell
s (to which regulatory functions have been ascribed) in recipient peri
pheral blood and especially in recipient bone marrow; and (e) an unexp
ectedly increased susceptibility to clinically significant infections
(primarily viral), and even death in the DBMC-infused group, compared
with controls, but no graft losses because of rejection in the DBMC-in
fused group, Mixed lymphocyte culture assays showed a trend toward a g
reater number of nonspecifically low reactors in the DBMC group, as we
ll as a greater number of nonspecifically high reactors in the control
s (P = 0.058), The autologous mixed lymphocyte reaction also indicated
a trend towards nonspecific immune activation in the DBMC group. Fina
lly, anti-cytomegaloviral IgG antibody reactivity was significantly in
hibited in the DBMC group 4-6 mo postoperatively (P = < 0.05), In the
controls, there were no donor cell lineages detected by PCR-flow in th
e peripheral blood, These rather unexpected findings, indicating a mor
e depressed cellular and humoral immune capacity in the DBMC cadaver k
idney transplant recipients in this relatively early follow-up period,
are discussed relevant to chimerism, MHC restriction, and suppressor
activity brought about by specialized DBMC subsets, which still need t
o be defined.